Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Pharma
Age
16–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male/female from 16 to 65 years
Well-characterized focal epilepsy or epileptic syndrome according to the International League Against Epilepsy (ILAE) classification
History of partial onset seizures
Subjects having at least 4 partial onset seizures during the 4-week Baseline Period and at least 2 partial onset seizures during the 3 months prior to Visit 1
Subjects taking 1 or 2 concomitant Antiepileptic drugs (AED(s)) that have been at a stable dose.
You may not be if
Seizure type IA non-motor as only seizure type
Seizures occurring only in clusters
Status epilepticus during the last 2 years before Visit 1
History of cerebrovascular accident (CVA)
Presence of any sign suggesting rapidly progressing brain disorder or brain tumor
Clareo Health | A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.
